Aspen

12/13 Exchange Place , I.F.S.C., Dublin 1, Ireland
Telephone: + 44 1748 828 391
Medical Information Direct Line: 0800 0087 392
Medical Information e-mail: aspenglobal@professionalinformation.co.uk

Patient Information Leaflet last updated on the eMC: 03/05/2011
PIL Lanoxin 125 Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 21/05/2009 and displayed until 03/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 06/05/2008 and displayed until 21/05/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 27/10/2005 and displayed until 06/05/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 14/06/2004 and displayed until 27/10/2005
Reasons for adding or updating:
  • Change to date of revision
  • Company name change or merger
Updated on 06/06/2003 and displayed until 14/06/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 27/06/2002 and displayed until 06/06/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   digoxin